Loading...

DIVISLAB Divis Laboratories Ltd Major contract awards or cancellations Announcement

Dvs

DVSL

Divis Laboratories Ltd

(DIVISLAB)

2025 Announcement

Summary

Summary

Revised Disclosures

Share Acquisition Disclosure

Re-lodgment Notification

Compliance Certificate

Management Change

KYC Update Notice

Earnings Call Transcript

Quarterly Results

Earnings Call Audio

Policy Amendment

Earnings Call Scheduled

Annual General Meeting

Compliance Certificate

AGM Announcement

Tax Deduction Info

Equity Shares Transfer

Long-Term Agreement

Earnings Call Summary

Financial Results Publication

Q4 FY25 Earnings Call

Secretarial Auditor Appoint...

Management Change

Annual Compliance Report

Earnings Call Scheduled

Management Change

Long-Term Agreement

Regulatory Compliance

Management Change

Earnings Call Transcript

Postal Ballot Notice

Financial Results Published

Earnings Call Audio

Management Changes

Director Reappointment

Earnings Call Scheduled

Compliance Submission

New Operations Launched

Penalty Disclosure

Media Report Clarification

Regulatory Penalty Issued

Earnings Call Transcript

Financial Results

Earnings Call Audio

Earnings Call Scheduled

Earnings Call Schedule

Compliance Submission

Credit Rating Reaffirmed

Earnings Call Transcript

Financial Results Publication

Earnings Conference Call In...

Certificate Submission

Notice Publication

Newspaper Clippings

Director Cessation

Deduction of Tax from Divid...

Earnings Call Transcript

Financial Results Publication

Compliance Amendment

Board Meeting Outcome

Compliance Submission

Earnings Conference Call

Capacity Addition

Certificate Submission

Compliance Certificate Subm...

Certificate Submission

Newspaper Publication

Newspaper Publication

Earnings Call Transcript

Financial Results Publication

Earnings Call Audio Uploaded

Management Appointments

Earnings Conference Call

Submission of Certificate u...

GST Order Update

Disclosure Order

Regulatory Action

Financial Results Publication

Earnings Call Transcript

Earnings Conference Call

Submission of Certificate

USFDA Visits Divis Choutupp...

USFDA Delegation Visit

Visit by USFDA Delegation

Resignation of Director

Financial Statements

Financial Statements

Earnings Guidance

Policy Amendment

Financial Statements, Earni...

Newspaper Publication

Financial Statements, Earni...

Financial Statements

Earnings Call Transcript

Management Changes

Publishing of Newspaper cli...

Dividend Disclosure

Earnings Call Transcript Up...

Financial Statements

Earnings Conference Call

External Links:

Data:

Divis Laboratories Ltd has signed a long-term manufacturing and supply agreement with a global pharma company, expecting a revenue contribution, with an estimated cost of capacity addition for manufacturing between Rs. 650-750 crores.

AI Assistant

Divis Laboratories Ltd

2025

Announcement

Find Answers

Ask about any part of the document to get insights, explanations, or key details.